Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Pennington Biomedical Research Center, Baton Rouge, Louisiana.
JAMA. 2014 Sep 3;312(9):943-52. doi: 10.1001/jama.2014.10432.
Even though one-third of US adults are obese, identification and treatment rates for obesity remain low. Clinician engagement is vital to provide guidance and assistance to patients who are overweight or obese to address the underlying cause of many chronic diseases.
To describe current best practices for assessment and lifestyle management of obesity and to demonstrate how the updated Guidelines (2013) for Managing Overweight and Obesity in Adults based on a systematic evidence review sponsored by the National Heart, Lung, and Blood Institute (NHLBI) can be applied to an individual patient.
Systematic evidence review conducted for the Guidelines (2013) for Managing Overweight and Obesity in Adults supports treatment recommendations in 5 areas (risk assessment, weight loss benefits, diets for weight loss, comprehensive lifestyle intervention approaches, and bariatric surgery); for areas outside this scope, recommendations are supported by other guidelines (for obesity, 1998 NHLBI-sponsored obesity guidelines and those from the National Center for Health and Clinical Excellence and Canadian and US professional societies such as the American Association of Clinical Endocrinologists and American Society of Bariatric Physicians; for physical activity recommendations, the 2008 Physical Activity Guidelines for Americans); a PubMed search identified recent systematic reviews covering depression and obesity, motivational interviewing for weight management, metabolic adaptation to weight loss, and obesity pharmacotherapy.
The first step in obesity management is to screen all adults for overweight and obesity. A medical history should be obtained assessing for the multiple determinants of obesity, including dietary and physical activity patterns, psychosocial factors, weight-gaining medications, and familial traits. Emphasis on the complications of obesity to identify patients who will benefit the most from treatment is more useful than using body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) alone for treatment decisions. The Guidelines (2013) recommend that clinicians offer patients who would benefit from weight loss (either BMI of ≥30 with or without comorbidities or ≥25 along with 1 comorbidity or risk factor) intensive, multicomponent behavioral intervention. Some clinicians do this within their primary care practices; others refer patients for these services. Weight loss is achieved by creating a negative energy balance through modification of food and physical activity behaviors. The Guidelines (2013) endorse comprehensive lifestyle treatment by intensive intervention. Treatment can be implemented either in a clinician's office or by referral to a registered dietitian or commercial weight loss program. Weight loss of 5% to 10% is the usual goal. It is not necessary for patients to attain a BMI of less than 25 to achieve a health benefit.
Screening and assessment of patients for obesity followed by initiation or referral of treatment should be incorporated into primary care practice settings. If clinicians can identify appropriate patients for weight loss efforts and provide informed advice and assistance on how to achieve and sustain modest weight loss, they will be addressing the underlying driver of many comorbidities and can have a major influence on patients' health status.
尽管美国有三分之一的成年人肥胖,但肥胖的识别和治疗率仍然很低。临床医生的参与对于为超重或肥胖患者提供指导和帮助至关重要,以解决许多慢性疾病的根本原因。
描述肥胖评估和生活方式管理的当前最佳实践,并展示基于国家心肺血液研究所(NHLBI)赞助的系统证据审查的 2013 年《管理超重和肥胖成年人指南》(以下简称《指南》)如何应用于个体患者。
为《指南》(2013 年)进行的系统证据审查支持 5 个领域(风险评估、减肥益处、减肥饮食、综合生活方式干预方法和减重手术)的治疗建议;对于超出此范围的领域,建议由其他指南支持(肥胖领域,1998 年 NHLBI 赞助的肥胖指南以及国家卫生与临床卓越中心和加拿大及美国专业协会的指南,如美国临床内分泌医师协会和美国减重医师协会;体力活动建议,2008 年《美国人体力活动指南》);PubMed 搜索确定了最近涵盖抑郁和肥胖、体重管理的动机性访谈、体重减轻的代谢适应以及肥胖药物治疗的系统评价。
肥胖管理的第一步是筛查所有超重和肥胖的成年人。应获取病史,评估肥胖的多个决定因素,包括饮食和体力活动模式、社会心理因素、增重药物和家族特征。强调肥胖的并发症,以确定最能从治疗中受益的患者,比仅使用体重指数(BMI;体重以千克为单位除以身高以米为单位)来做出治疗决策更有用。《指南》(2013 年)建议临床医生为那些可能受益于减肥的患者提供强化、多组分的行为干预,无论是 BMI 为≥30 伴或不伴合并症,还是 BMI 为≥25 伴 1 种合并症或危险因素。一些临床医生在其初级保健实践中这样做;其他人则将患者转介给这些服务。通过改变食物和体力活动行为来创造负能量平衡从而实现减肥。《指南》(2013 年)支持通过强化干预进行综合生活方式治疗。治疗可以在医生办公室进行,也可以通过转介给注册营养师或商业减肥计划进行。通常目标是减轻 5%至 10%的体重。患者不必将 BMI 降低到 25 以下就能获得健康益处。
应将肥胖患者的筛查和评估以及治疗的启动或转介纳入初级保健实践中。如果临床医生能够识别出适合减肥的患者,并就如何实现和维持适度减肥提供明智的建议和帮助,他们将解决许多合并症的根本原因,并对患者的健康状况产生重大影响。